Investor Stock List
Ranked #3,927 of 8,699 institutional investors

Ikarian Capital, LLC

Dallas, TX

$440M
US stock portfolio at live prices · today −$4.9M (−1.10%)
Live prices, last trade 10:30 AM ET
Value at quarter end (Q3 2026)
$504M
Change from Q2 2026
−$106.8M (−17.48%)
Positions
108 · 15 new, 14 sold out
Filed
Nov 16, 2026

Not counted in the ranking: call options on $168M of stock, put options on $322M. $51.8M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
KOD 12.0%PCVX 5.23%ABVX 4.58%SLN 3.70%AMLX 3.31%
StockSharesValue, live% of portfoliovs Q2 2026
KOD Kodiak Sciences Inc.533,113$52.9M12.0%Reduced −50%
PCVX Vaxcyte, Inc.400,465$23.0M5.23%Added +3%
ABVX ABIVAX Société Anonyme285,909$20.2M4.58%Reduced −13%
SLN Silence Therapeutics plc821,790$16.3M3.70%Added +394%
AMLX Amylyx Pharmaceuticals, Inc.561,459$14.6M3.31%Added +378%
CLDX Celldex Therapeutics, Inc.518,500$14.3M3.24%Added +8%
ANRO Alto Neuroscience Inc482,338$12.3M2.80%Added +18%
RCUS Arcus Biosciences, Inc.734,559$11.9M2.70%Added +46%
ELVN Enliven Therapeutics, Inc.232,055$10.9M2.47%Added +83%
VERA Vera Therapeutics, Inc.400,000$10.5M2.39%Added +29%
ANIP ANI Pharmaceuticals, Inc.149,065$10.3M2.35%Reduced −45%
COGT Cogent Biosciences, Inc.370,084$10.1M2.29%Unchanged
MAZE Maze Therapeutics, Inc.301,402$9.6M2.18%Reduced −20%
VRDN Viridian Therapeutics, Inc.225,000$6.9M1.58%Reduced −47%
JBIO Jade Biosciences, Inc.427,349$6.6M1.49%Unchanged
TECX Tectonic Therapeutic, Inc.306,338$6.4M1.46%Added +49%
ACOG Alpha Cognition Inc.701,259$6.2M1.41%Reduced −16%
MNPR Monopar Therapeutics Inc.86,761$5.9M1.35%Added +81%
CTNM Contineum Therapeutics, Inc.594,666$5.3M1.20%Reduced −26%
VOR Vor Biopharma Inc.250,000$4.9M1.10%New
CCCC C4 Therapeutics, Inc.1,933,000$4.8M1.09%Reduced −21%
EPRX Eupraxia Pharmaceuticals Inc.809,741$4.8M1.08%Unchanged
OVID Ovid Therapeutics Inc.2,119,704$4.7M1.08%Reduced −7%
ALEC Alector, Inc.1,982,606$4.7M1.07%Unchanged
IMNM Immunome, Inc.285,000$4.7M1.06%Added +375%
RLMD Relmada Therapeutics, Inc.1,448,359$4.2M0.96%Reduced −33%
ORIC ORIC Pharmaceuticals, Inc.522,765$4.1M0.93%New
SPRB Spruce Biosciences, Inc.101,356$4.0M0.91%Reduced −16%
IRLA IRulya Therapeutics Inc.95,652$3.9M0.89%Added +32%
SEPN Septerna, Inc.100,047$3.9M0.88%New
IVA Inventiva S.A.1,129,101$3.8M0.86%Unchanged
RZLT Rezolute, Inc.935,012$3.8M0.85%Unchanged
CAMP Camp4 Therapeutics Corp912,906$3.7M0.83%New
FRNM Freenome, Inc.362,626$3.4M0.78%New
CPIX Cumberland Pharmaceuticals Inc.503,153$3.2M0.73%Unchanged
CRDL Cardiol Therapeutics Inc.3,325,000$2.9M0.65%Unchanged
QTTB Q32 Bio Inc.345,000$2.9M0.65%Reduced −20%
OCGN Ocugen, Inc.3,562,972$2.8M0.64%Reduced −10%
VOGX Vogenx, Inc.208,836$2.8M0.63%New
OLMA Olema Oncology, Inc.383,281$2.7M0.62%Unchanged
PEPG PepGen Inc.693,539$2.7M0.61%Added +55%
DCTH Delcath Systems, Inc.135,667$2.6M0.58%Reduced −27%
ARVN Arvinas, Inc.358,257$2.4M0.54%Unchanged
PRAX Praxis Precision Medicines, Inc.6,942$2.1M0.49%Reduced −90%
ACAD Acadia Pharmaceuticals Inc.112,000$2.0M0.45%Added +299%
DNA Ginkgo Bioworks Holdings, Inc.250,000$2.0M0.45%New
OBX Obsidian Therapeutics, Inc.158,942$1.9M0.43%New
DRUG Bright Minds Biosciences Inc.88,951$1.8M0.42%Unchanged
PTHS Pelthos Therapeutics Inc.256,598$1.8M0.41%Unchanged
CAPR Capricor Therapeutics, Inc.229,215$1.7M0.40%Reduced −62%
FTH Faeth Therapeutics, Inc.199,694$1.7M0.39%Added +464%
FULC Fulcrum Therapeutics, Inc.449,161$1.7M0.38%Reduced −57%
LXEO Lexeo Therapeutics, Inc.513,011$1.6M0.37%Unchanged
FDMT 4D Molecular Therapeutics, Inc.150,037$1.6M0.37%New
VSTM Verastem, Inc.213,865$1.4M0.32%Unchanged
IMUX Immunic, Inc.182,464$1.3M0.30%Added +170%
TYRA Tyra Biosciences, Inc.65,000$1.3M0.30%New
KZIA Kazia Therapeutics Limited246,201$1.3M0.29%Reduced −38%
TARS Tarsus Pharmaceuticals, Inc.16,858$1.3M0.29%Reduced −46%
CUE Cue Biopharma, Inc.290,633$1.2M0.28%Added +178%
IVVD Invivyd, Inc.2,656,570$1.2M0.28%Unchanged
RNTX Rein Therapeutics Inc.2,950,000$1.1M0.25%Unchanged
HROW Harrow, Inc.33,275$1.0M0.24%Reduced −75%
STIM Neuronetics, Inc.810,182$952K0.22%Added +16%
DBVT DBV Technologies S.A.90,591$858K0.19%Reduced −12%
DERM Journey Medical Corporation251,436$850K0.19%Unchanged
IBIO iBio, Inc.957,062$769K0.17%Unchanged
LPCN Lipocine Inc.508,556$748K0.17%Unchanged
CABA Cabaletta Bio, Inc.700,000$707K0.16%Unchanged
QNRX Quoin Pharmaceuticals, Ltd.211,538$703K0.16%Unchanged
PMN ProMIS Neurosciences, Inc.205,000$652K0.15%Unchanged
PTN Palatin Technologies, Inc.130,000$639K0.15%New
AVTX Avalo Therapeutics, Inc.90,183$616K0.14%Unchanged
PLRX Pliant Therapeutics, Inc.1,000,000$599K0.14%Unchanged
LYEL Lyell Immunopharma, Inc.41,081$578K0.13%Unchanged
CNSP CNS Pharmaceuticals, Inc.135,830$500K0.11%Unchanged
NMRA Neumora Therapeutics, Inc.1,278,408$418K<0.1%Unchanged
PALI Palisade Bio, Inc.400,000$382K<0.1%Reduced −47%
EQ Equillium, Inc.303,555$346K<0.1%Unchanged
KLRS Kalaris Therapeutics, Inc.248,257$338K<0.1%Reduced −31%
ANL Adlai Nortye Group Ltd.33,899$298K<0.1%Unchanged
FHTX Foghorn Therapeutics Inc.160,000$282K<0.1%New
SLDB Solid Biosciences Inc.42,956$275K<0.1%Unchanged
LXRX Lexicon Pharmaceuticals, Inc.164,674$274K<0.1%Unchanged
AEON AEON Biopharma, Inc.2,203,406$274K<0.1%New
AVR Anteris Technologies Global Corp.50,862$259K<0.1%Reduced −69%
SION Sionna Therapeutics, Inc.85,300$250K<0.1%New
VKTX Viking Therapeutics, Inc.9,717$248K<0.1%Unchanged
PURR Hyperliquid Strategies Inc.30,001$235K<0.1%Unchanged
ABOS Acumen Pharmaceuticals, Inc.1,053,797$185K<0.1%Unchanged
TENX Tenax Therapeutics, Inc.136,648$181K<0.1%Reduced −83%
ALMS Alumis Inc.41,177$172K<0.1%Reduced −95%
EVAX Evaxion A/S74,698$172K<0.1%Unchanged
MGNX MacroGenics, Inc.74,893$154K<0.1%Unchanged
ENVB Enveric Biosciences, Inc.100,002$144K<0.1%Unchanged
RNAC Cartesian Therapeutics, Inc.20,807$129K<0.1%Unchanged
BCRX BioCryst Pharmaceuticals, Inc.16,756$122K<0.1%Unchanged
CMPS COMPASS Pathways plc15,000$119K<0.1%Unchanged
PMVP PMV Pharmaceuticals, Inc.89,136$108K<0.1%Unchanged
NEUP Neuphoria Therapeutics Inc.47,443$108K<0.1%Unchanged
TRAW Traws Pharma, Inc.478,142$105K<0.1%Unchanged
VTGN Vistagen Therapeutics, Inc.519,077$97K<0.1%Unchanged
VYGR Voyager Therapeutics, Inc.53,063$86K<0.1%Unchanged
CMMB Chemomab Therapeutics Ltd.51,793$66K<0.1%Unchanged
EYPT EyePoint, Inc.205,056$52K<0.1%New
MGRX Mangoceuticals, Inc.138,146$18K<0.1%Unchanged
CMPX Compass Therapeutics, Inc.18,000$13K<0.1%Unchanged
AIRS AirSculpt Technologies, Inc.16,398$10K<0.1%Unchanged

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
BBIO BridgeBio Pharma, Inc.57,417$4.4M
HIMS Hims & Hers Health, Inc.188,381$2.9M
RARE Ultragenyx Pharmaceutical Inc.165,617$2.8M
CLYM Climb Bio Inc300,000$2.7M
ABSI Absci Corporation353,772$2.7M
NXTC NextCure, Inc.288,303$1.9M
TRAX First Tracks Biotherapeutics, Inc.42,775$1.8M
ARWR Arrowhead Pharmaceuticals, Inc.38,278$1.6M
ANNX Annexon, Inc.430,244$1.4M
BIOA BioAge Labs, Inc.200,000$924K
LABD Direxion Daily S&P Biotech Bear 3X Shares105,822$906K
PASG Passage Bio, Inc.99,517$349K
WVE Wave Life Sciences, Inc.85,285$232K
ELTX Elicio Therapeutics, Inc.100,000$159K